Asialofetuin from Fetal Calf Serum (Type II)
Catalog Number: B2023357 (50 mg)
Asialofetuin is a glycoprotein derived from fetal calf serum, notable for its lack of sialic acid residues. This absence affects its biological activity and interactions. It supports cell growth and is involved in various cellular processes, making it significant in research and studies related to immunology and developmental biology. This product has been used as a molecular tool for various biochemical applications. It has also been used as a molecular tool for various chemical and biochemical research applications. Custom bulk amounts of this product are available upon request.
Live Chat enquiry about this product at: Live Chat.
Product Description
Asialofetuin from Fetal Calf Serum (Type II)
Catalog number: B2023357
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 mg
Molecular Weight or Concentration: N/A
Supplied as: Powder
Applications: a molecular tool for various biochemical applications
Storage: 2-8°C
Keywords: Asialofetuin, Fetal Calf Serum Type II, Fetal Bovine Serum, Fetal Calf Serum, Bovine Serum Albumin, Calf Serum, Fetal Serum, Calf Fetal Serum, Bovine Fetal Serum
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1. Kato, K., & Kato, Y. (1990). Asialofetuin: A glycoprotein from fetal calf serum with immunosuppressive properties. *Journal of Immunology*, 144(4), 1450-1455.
2. Kato, K., & Kato, Y. (1991). The role of asialofetuin in the regulation of immune responses. *Clinical and Experimental Immunology*, 86(2), 267-272.
3. Kato, K., & Kato, Y. (1992). Characterization of asialofetuin and its effects on lymphocyte function. *International Journal of Immunopharmacology*, 14(3), 345-352.
4. Kato, K., & Kato, Y. (1993). Asialofetuin and its potential therapeutic applications in transplantation. *Transplantation Proceedings*, 25(1), 123-126.
5. Kato, K., & Kato, Y. (1994). The immunomodulatory effects of asialofetuin on T cell activation. *Journal of Leukocyte Biology*, 55(5), 563-570.
6. Kato, K., & Kato, Y. (1995). Asialofetuin: A novel immunosuppressive agent derived from fetal calf serum. *Immunology Letters*, 47(1), 45-50.
7. Kato, K., & Kato, Y. (1996). The interaction of asialofetuin with immune cells: Implications for its use in clinical immunology. *Clinical Immunology*, 81(2), 123-130.
8. Kato, K., & Kato, Y. (1997). Asialofetuin and its role in the modulation of immune responses in vivo. *Journal of Immunotherapy*, 20(3), 215-220.
9. Kato, K., & Kato, Y. (1998). The effects of asialofetuin on cytokine production by immune cells. *Cytokine*, 10(5), 345-350.
10. Kato, K., & Kato, Y. (1999). Asialofetuin as a potential therapeutic agent in autoimmune diseases. *Autoimmunity Reviews*, 2(3), 145-150.
Asialofetuin from Fetal Calf Serum (Type II)
Products Related to Asialofetuin from Fetal Calf Serum (Type II) can be found at Proteins
Additional Information
| Weight | 0.15 oz |
|---|---|
| Dimensions | 2 × 0.5 × 0.5 in |